Dave Resnicoff Discusses FCPA Compliance Challenges for Growing Global Life-Sciences Companies in New Anti-Corruption Report
RSHC Partner Dave Resnicoff discusses FCPA compliance challenges facing fast-growing life-sciences companies raised by Alexion Pharmaceutical’s $21 million FCPA settlement with SEC in the July 22, 2020 edition of the Anti-Corruption Report.